Gamunex-c 40 gram/400 ML vial 400ML
Ended Awarded Last action
- Contract number
- SPE2DR26FG3WH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,958
Award facts
- Contract value 100% obligated
- $18,957.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $18,957.92 delivery order to AmerisourceBergen Drug Corp (a subsidiary of Cencora, Inc.) on January 28, 2026, for the supply of Gamunex-C 40 gram/400 milliliter vials. This firm fixed-price, non-set-aside contract is scheduled for completion by February 19, 2026, with performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
Gamunex-C is an intravenous immunoglobulin therapy used to treat various immunodeficiency conditions and autoimmune disorders, reflecting the critical specialty pharmaceutical products that DLA procures to support Defense Health Agency operations and military treatment facilities. AmerisourceBergen's position as a major pharmaceutical distributor and its established IDC with DLA demonstrates its established capability to fulfill federal medical procurement requirements through competitive procurement processes. The parent company, Cencora, Inc., also holds a $999,999,999.00 IDC with DLA Troop Support Medical extending through December 2031, further solidifying the organization's role as a strategic partner in the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26FG3WH?
SPE2DR26FG3WH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FG3WH worth?
The government has obligated $18,958 on SPE2DR26FG3WH.
Is contract SPE2DR26FG3WH an order under another contract?
Yes. SPE2DR26FG3WH is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG3WH competed?
The extent of competition for SPE2DR26FG3WH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award